Piga - phosphatidylinositol glycan anchor biosynthesis, class A Gene
Species: Rattus norvegicus
Summary
Predicted to enable phosphatidylinositol N-acetylglucosaminyltransferase activity. Predicted to be involved in GPI anchor biosynthetic process. Predicted to act upstream of or within cellular response to Leukemia Inhibitory Factor. Predicted to be located in endoplasmic reticulum membrane. Predicted to be part of glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex. Human ortholog(s) of this gene implicated in multiple congenital anomalies-hypotonia-seizures syndrome 2 and paroxysmal nocturnal hemoglobinuria. Orthologous to human PIGA (phosphatidylinositol glycan anchor biosynthesis class A). [provided by Alliance of Genome Resources, Apr 2022]
Piga Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001108816.2 | NP_001102286.1 | phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform 2 |
| NM_001401036.1 | NP_001387965.1 | phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
phosphatidylinositol N-acetylglucosaminyltransferase subunit A |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS10487 | PIGA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service